Recordati Partners Well
These days, Italy is a tough country for drug makers to have as a home base, because the government imposes some of the strictest price controls in the world. Even highly innovative products are priced 30-40% lower than they are in other countries. Recordati, like other native Italian firms, has responded to the strictures by extending its marketing reach into other countries.
You may also be interested in...
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.